|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61K 9/50 | (2006.01) | ||
| C07D 209/34 | (2006.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/496 | (2006.01) |
| (11) | Patento numeris | 3463315 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17807296.3 |
| Europos patento paraiškos padavimo data | 2017-05-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/034795 |
| Data | 2017-05-26 |
| (87) | Numeris | WO 2017/210132 |
| Data | 2017-12-07 |
| (30) | Numeris | Data | Šalis |
| 201662344870 P | 2016-06-02 | US | |
| 201662344878 P | 2016-06-02 | US |
| (72) |
NI, Jinsong , US
YANG, Rong , US
|
| (73) |
ADS Therapeutics LLC ,
15615 Alton Parkway, Suite 450, Irvine, CA 92618-3308,
US
|
| (54) | COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION |
| COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION |